TRAP5b new serum marker for metastatic melanoma

Wen-Jen Hwu
March 2008
Hem/Onc Today;3/10/2008, Vol. 9 Issue 4, p33
The article discusses research on tartrate-resistant acid phosphatase isoform 5b (TRAP5b) as a serum marker presented during a meeting of the American Academy of Dermatology in San Antonio, Texas from February 1 to 5, 2008. According to researcher Dr. Ana-Maria Forsea of Elias University Hospital in Romania, TRAP5b is a specific marker for metastatic melanoma in patients. It is mentioned that the marker may be used to diagnose bone metastases.


Related Articles

  • Does Immunotherapy Have Any Value In the Treatment of Malignant Melanomas? Roenigk Jr., Henry H. // Journal of Dermatologic Surgery & Oncology;Feb79, Vol. 5 Issue 2, p132 

    To date, immunotherapy has not proven to be curative of malignant melanomas. Some immunologic procedures have produced regressions of sonic recurrences and perhaps have prolonged life by eliminating some dispersed malignant cells that would have gone to metastasis, but have not affected...

  • Results of systemic treatment of cutaneous melanoma in inoperable stage III and IV. Cybulska-Stopa, Bożena; Skoczek, Marta; Ziobro, Marek; Świtaj, Tomasz; Falkowski, Sławomir; Morysiński, Tadeusz; Hetnał, Marcin; Cedrych, Ida; Rutkowski, Piotr // Contemporary Oncology / Wspolczesna Onkologia;2012, Vol. 16 Issue 6, p532 

    Aim of the study: The incidence of melanoma is increasing rapidly worldwide. Metastatic melanoma is still an incurable disease, although an era of new drugs is approaching. Current methods to predict outcomes in patients with advanced, metastatic melanoma are limited. A retrospective analysis of...

  • Surgical Management of Advanced Cutaneous Malignant Melanoma. Schour, Lionel // Journal of Dermatologic Surgery & Oncology;Feb79, Vol. 5 Issue 2, p114 

    In the past, surgical treatment of cutaneous melanoma has been determined largely by assessment of the regional nodes by clinical palpation. More recently, an increasing number of reports indicate that measurement of the histologic thickness of primary melanomas and evaluation of tile level of...

  • Density of DC-LAMP+ mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor. Ladányi, Andrea; Kiss, Judit; Somlai, Beáta; Gilde, Katalin; Fejős, Zsuzsanna; Mohos, Anita; Gaudi, István; Tímár, József // Cancer Immunology, Immunotherapy;Sep2007, Vol. 56 Issue 9, p1459 

    As the most potent antigen presenting cells, dendritic cells (DCs) play key roles in the immune response against tumors. Their density in the tumor tissue has been associated with prognosis in patients with various cancers. However, few studies have been aimed at the presence and maturation...

  • MicroRNA and cutaneous melanoma: from discovery to prognosis and therapy. Segura, Miguel F.; Greenwald, Holly S.; Hanniford, Doug; Osman, Iman; Hernando, Eva // Carcinogenesis;Oct2012, Vol. 33 Issue 10, p1823 

    Melanoma incidence and associated mortality continue to increase worldwide. The lack of treatments with durable responses for stage IV melanoma may be due, at least in part, to an incomplete understanding of the molecular mechanisms that regulate tumor initiation and/or progression to...

  • Clonal Persistence and Evolution During a Decade of Recurrent Melanoma. Wang, Ena; Voiculescu, Sonia; Le Poole, Isabelle C.; El-Gamil, Mona; Xin Li; Sabatino, Marianna; Robbins, Paul F.; Nickoloff, Brian J.; Marincola, Francesco M. // Journal of Investigative Dermatology;Jun2006, Vol. 126 Issue 6, p1372 

    A patient with metastatic cutaneous melanoma responsive to immunotherapy experienced several recurrences over a decade of observation. With each recurrence, biopsies were obtained and cell lines generated. A rare mutation of the β-catenin gene and an unbalanced methylation of the androgen...

  • Artificial Tanning Dangers.  // Massage & Bodywork;Aug/Sep2002, Vol. 17 Issue 4, p12 

    Examines the damaging effects of tanning beds and sun lamps on the skin. Development of squamo cell and basal cell carcinoma; Incidence of melanoma symptoms; Restrictions from using artificial tanning devices.

  • The incidental malignant melanoma. Monk, B.E.; Clement, M.I.; Pembroke, A.C.; Du Vivier, Anthony // British Medical Journal (Clinical Research Edition);8/13/1983, Vol. 287 Issue 6390, p485 

    Presents cases of patients incidentally diagnosed with malignant melanoma. Essence of a thorough skin examination as a part of the general medical examination; Increase in the incidence and mortality of malignant melanoma; Relation between the prognosis of malignant melanoma and depth of...

  • Pyogenic granuloma vs amelanotic melanoma. Jordan, Andy // Pulse;5/18/2011, Vol. 71 Issue 18, p21 

    The article offers information on the difference between the two skin conditions, pyogenic granuloma and amelanotic melanoma.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics